let me go out on a limb. sales of alferon at this point are utterly meaningless. they are not marketing it and the sales are anecdotal.
the reason for the call is that they apparently have a drug which is about to be submitted to the fda with approval meaning the opening of a multibillion dollar market for which there is no current drug.
a management so aloof as to pull off a plumb crappy financing, would hardly care to explain to shareholders poor sales of a drug for which sales are not meaningful in any event.
the cc is meant to serve the pr interests of the company. since there is no positive comments on the board, i take it as a a contrarian sign.